AI assistant
Hilan Ltd. — Interim / Quarterly Report 2024
Apr 28, 2025
6834_rns_2025-04-28_9b4730bb-a0b6-4bb1-9a1c-c5cb3bc27c06.pdf
Interim / Quarterly Report
Open in viewerOpens in your device viewer
HILAN LTD.
CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
AS OF DECEMBER 31, 2024
INDEX
| Page | |
|---|---|
| Auditors' Letter | 2 |
| Condensed Consolidated Balance Sheets | 3 - 4 |
| Condensed Consolidated Statements of Comprehensive Income | 5 |
| Condensed Consolidated Statements of Changes in Equity | 6 |
| Condensed Consolidated Statements of Cash Flows | 7 - 9 |
This document is an unofficial translation of part of the Hebrew original of the Financial Reports published by the Company on March 18, 2025 (reference no.: 2025-01-017771) on the Tel-Aviv Stock Exchange website and the Israeli Securities Authority website (hereinafter: the "Hebrew Version"). This document is provided for convenience purposes only. This document is not an official translation and has no legal standing. The Hebrew Version is the sole legally binding version. In case of discrepancy or inconsistency between this translation and the Hebrew Version, the Hebrew Version shall prevail .

';lkKost Forer Gabbay & Kasierer 144 Menachem Begin Road, Building A, Tel-Aviv 6492102, Israel
Tel: +972-3-6232525 Fax: +972-3-5622555 ey.com
To Hilan Ltd.
We have audited, in accordance with generally accepted auditing standards in Israel, the consolidated balance sheets of Hilan Ltd. ("the Company") as of December 31, 2024 and 2023 and the related consolidated statements of comprehensive income, changes in equity and cash flows for each of the three years in the period ended December 31, 2024.
Based on our audits, in our report dated March 17, 2025, we expressed an unqualified opinion on those statements.
The accompanying financial statements, which are derived from the abovementioned financial statements, are condensed financial statements and do not include disclosures required by International Financial Reporting Standards. If the omitted disclosures were included in the accompanying financial statements, they might influence the user's conclusions about the consolidated financial position, results of operations and cash flows of the Company and subsidiaries. Accordingly, the accompanying financial statements are not designed for those who are not informed about such matters.
Tel-Aviv, Israel March 17, 2025 KOST FORER GABBAY & KASIERER A Member of Ernst & Young Global
CONDENSED CONSOLIDATED BALANCE SHEETS
| December 31, | ||
|---|---|---|
| 2024 | 2023 | |
| NIS in thousands | ||
| ASSETS | ||
| CURRENT ASSETS: | ||
| Cash and cash equivalents | 343,005 | 300,633 |
| Trade receivables | 828,202 | 791,483 |
| Other accounts receivable | 51,365 | (*) 38,027 |
| Fund held for clients | 576,682 | )*( 117,115 |
| Taxes receivable | 3,700 | 4,419 |
| Inventories | 1,985 | 4,218 |
| 1,804,939 | 1,255,895 | |
| NON-CURRENT ASSETS: | ||
| Investments in companies accounted for at equity | 3,330 | 5,161 |
| Investments in financial assets at fair value through profit or loss |
6,373 | 3,654 |
| Long-term loans and receivables | 29,450 | 15,691 |
| Property, plant and equipment | 110,611 | 77,308 |
| Right-of-use assets | 216,181 | 213,296 |
| Intangible assets | 210,309 | 157,188 |
| Goodwill | 707,740 | 597,037 |
| Employee benefit assets, net | 47 | 5,919 |
| Deferred taxes | 18,142 | 15,252 |
| 1,302,183 | 1,090,506 | |
| 3,107,122 | 2,346,401 |
(*) Reclassified.
CONDENSED CONSOLIDATED BALANCE SHEETS
| December 31, | ||
|---|---|---|
| 2024 | 2023 | |
| NIS in thousands | ||
| - | ||
| 24,375 | ||
| 5,925 | ||
| 48,939 | ||
| 311,182 | ||
| (*) 405,083 | ||
| (*) 117,115 | ||
| 15,734 | ||
| 93,186 | 93,218 | |
| 1,021,571 | ||
| 30,000 | 50,000 | |
| 19,396 | ||
| 166,995 | ||
| 22,255 | ||
| 54,927 | ||
| 356,650 | 313,573 | |
| 28,853 | 28,838 | |
| 212,776 | 209,846 | |
| - | ||
| 5,970 | ||
| )69,625( | ||
| 820,608 | ||
| 995,637 | ||
| 15,409 | 15,620 | |
| 1,155,025 | 1,011,257 | |
| 3,107,122 | 2,346,401 | |
| 2,330 20,000 17,258 58,002 316,058 495,681 575,985 16,947 1,595,447 16,851 191,805 32,326 85,668 2,441 6,137 (111,700) 1,001,109 1,139,616 |
(*) Reclassified.
March 17, 2025
| Date of approval of the | Avi Baum | Eli Zybert | Tal Waiser |
|---|---|---|---|
| financial statements | Chairman of the Board | CEO | CFO |
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME
| Year ended December 31, | ||||
|---|---|---|---|---|
| 2024 2023 |
2022 | |||
| NIS in thousands (except per share data) | ||||
| Revenues Cost of revenues |
2,838,589 2,195,128 |
2,588,797 2,013,260 |
2,232,859 1,716,678 |
|
| Gross profit | 643,461 | 575,537 | 516,181 | |
| Selling and marketing expenses | 107,596 | 99,962 | 103,626 | |
| General and administrative expenses | 209,009 | 191,096 | 172,478 | |
| Other income | 3,081 | 4,298 | - | |
| Operating income | 329,937 | 288,777 | 240,077 | |
| Finance income | 27,482 | 15,108 | 13,796 | |
| Finance expenses | (35,544) | )23,483( | )23,064( | |
| Group's share of loss of company accounted for at equity | (1,831) | )331( | )1,472( | |
| Income before taxes on income | 320,044 | 280,071 | 229,337 | |
| Taxes on income | 72,439 | 62,934 | 55,042 | |
| Net income | 247,605 | 217,137 | 174,295 | |
| Other comprehensive income (net of tax effect): Amounts that will not be subsequently reclassified to profit or loss: Remeasurement gain from defined benefit plans Profit from cash flow financing transactions |
2,789 - |
1,569 - |
5,126 2,524 |
|
| Amounts that will be or that have been reclassified to profit or loss when specific conditions are met: Gain (loss) from cash flow hedges Reclassification to profit or loss for cash flow hedges |
819 (864) |
)333( )622( |
97 778 |
|
| Adjustments arising from translating financial statements of | ||||
| foreign operations | 211 | 2,964 | 11,501 | |
| Total other comprehensive income | 2,955 | 3,578 | 20,026 | |
| Total comprehensive income | 250,560 | 220,715 | 194,321 | |
| Net income attributable to: | ||||
| Equity holders of the Company | 246,520 | 216,160 | 173,513 | |
| Non-controlling interests | 1,085 | 977 | 782 | |
| 247,605 | 217,137 | 174,295 | ||
| Total comprehensive income attributable to: | ||||
| Equity holders of the Company | 249,464 | 219,745 | 193,479 | |
| Non-controlling interests | 1,096 | 970 | 842 | |
| 250,560 | 220,715 | 194,321 | ||
| Net earnings per share attributable to equity holders of the Company (in NIS): |
||||
| Basic net earnings | 10.75 | 9.42 | 7.61 | |
| Diluted net earnings | 10.50 | 9.18 | 7.48 |
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY
| Attributable to equity holders of the Company | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Share capital |
Share premium |
Treasury shares |
Reserve from share-based payment transactions |
Reserve from transactions with non-controlling interests |
Foreign currency translation reserve |
Retained earnings |
Total | Non controlling interests |
Total equity |
|
| Balance as of January 1, 2022 |
28,468 | 144,109 | (5,217) | 1,965 | NIS in thousands (69,625) |
(8,408) | 504,502 | 595,794 | 9,411 | 605,205 |
| Net income Total other comprehensive income, net |
- - |
- - |
- - |
- - |
- - |
- 14,858 |
173,513 5,108 |
173,513 19,966 |
782 60 |
174,295 20,026 |
| Total comprehensive income Dividend to equity holders of the Company |
- - |
- - |
- - |
- - |
- - |
14,858 - |
178,621 )22,912( |
193,479 )22,912( |
842 - |
194,321 )22,912( |
| Issue of share capital (net issue expenses of NIS 470 thousand) Transfer from a translation fund for the acquisition of a |
370 | 70,954 | - | )2,822( | - | - | - | 68,502 | - | 68,502 |
| consolidated company Cost of share-based payment |
- - |
- - |
- - |
- 857 |
- - |
)2,498( - |
- - |
)2,498( 857 |
)26( 2,657 |
)2,524( 3,514 |
| Balance as of December 31, 2022 |
28,838 | 215,063 | )5,217( | - | )69,625( | 3,952 | 660,211 | 833,222 | 12,884 | 846,106 |
| Net income Total other comprehensive income (loss), net |
- - |
- - |
- - |
- - |
- - |
- 2,018 |
216,160 1,567 |
216,160 3,585 |
977 )7( |
217,137 3,578 |
| Total comprehensive income Dividend to equity holders of the Company Non-controlling interests arising from initially consolidated |
- - |
- - |
- - |
- - |
- - |
2,018 - |
217,727 )57,330( |
219,745 )57,330( |
970 - |
220,715 )57,330( |
| companies Cancellation of treasury shares Cost of share-based payment |
- - - |
- )5,217( - |
- 5,217 - |
- - - |
- - - |
- - - |
- - - |
- - - |
113 - 1,653 |
113 - 1,653 |
| Balance as of December 31, 2023 |
28,838 | 209,846 | - | - | )69,625( | 5,970 | 820,608 | 995,637 | 15,620 | 1,011,257 |
| Net income Total other comprehensive income, net |
- - |
- - |
- - |
- - |
- - |
- 167 |
246,520 2,777 |
246,520 2,944 |
1,085 11 |
247,605 2,955 |
| Total comprehensive income Dividend to equity holders of the Company Issue of share capital Exercise of options by non-controlling interest holders Cost of share-based payment |
- - 15 - - |
- - 2,930 - - |
- - - - - |
- - (2,930) - 5,371 |
- - - (42,075) - |
167 - - - - |
249,297 (68,796) - - - |
249,464 (68,796) 15 (42,075) 5,371 |
1,096 - - (2,303) 996 |
250,560 (68,796) 15 (44,378) 6,367 |
| Balance as of December 31, 2024 |
28,853 | 212,776 | - | 2,441 | (111,700) | 6,137 | 1,001,109 | 1,139,616 | 15,409 | 1,155,025 |
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
| Year ended December 31, | |||
|---|---|---|---|
| 2024 | 2023 | 2022 | |
| NIS in thousands | |||
| Cash flows from operating activities: | |||
| Net income | 247,605 | 217,137 | 174,295 |
| Adjustments to reconcile net income to net cash provided by operating activities: |
|||
| Adjustments to the profit or loss items: | |||
| Depreciation and amortization | 114,064 | 106,415 | 100,535 |
| Cost of share-based payment | 6,367 | 1,653 | 3,514 |
| Gain from sale of property, plant and equipment, net | (391) | )1,044( | )36( |
| Gain from deduction of Right of use asset | (109) | )22( | )142( |
| Finance expenses, net | 2,622 | 8,781 | 8,878 |
| Group's share of losses of company accounted for at equity | 1,831 | 331 | 1,472 |
| Taxes on income | 72,439 | 62,934 | 55,042 |
| Change in employee benefit liabilities, net | 6,948 | 2,637 | 1,190 |
| 203,771 | 181,685 | 170,453 | |
| Changes in asset and liability items: | |||
| Decrease (increase) in trade receivables |
9,218 | )62,762( | )141,095( |
| Decrease (increase) in other accounts receivable |
1,116 | )8,945( | 4,326 |
| Decrease (increase) in inventories |
2,233 | )3,460( | )758( |
| Increase (decrease) in trade payables |
(30,060) | 40,704 | 66,812 |
| Increase in other accounts payable | 61,749 | 33,538 | 27,431 |
| Increase (decrease) in deferred revenues and customer |
|||
| advances | (8,593) | 22,494 | 5,662 |
| 35,663 | 21,569 | )37,622( | |
| Cash paid and received during the year for: | |||
| Interest paid | (14,046) | )8,805( | )6,870( |
| Interest received | 9,619 | 5,581 | 245 |
| Taxes paid | (64,878) | )63,758( | (60,231) |
| Taxes received | 5,132 | 2,101 | 4,796 |
| (64,173) | )64,881( | )62,060( | |
| Net cash provided by operating activities | 422,866 | 355,510 | 245,066 |
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
| Year ended December 31, | |||
|---|---|---|---|
| 2024 2023 |
2022 | ||
| NIS in thousands | |||
| Cash flows from investing activities: | |||
| Purchase of property, plant and equipment | (55,643) | )55,858( | )14,047( |
| Acquisition of initially consolidated company (a) | (137,087) | )2,409( | )369,179( |
| Purchase of intangible assets | (742) | )1,983( | )3,014( |
| Acquisition of company accounted for at equity |
- | )5,492( | - |
| Proceeds from sale of property, plant and equipment | 987 | 1,239 | 501 |
| Repayment of investment in lease | 1,743 | 3,085 | 2,158 |
| Long-term loans | - | )1,845( | )2,496( |
| Proceeds from sale of financial assets measured at fair | |||
| value through profit or loss | 9,664 | - | - |
| Acquisition of financial assets measured at fair value | |||
| through profit or loss | (2,329) | )1,111( | )478( |
| Receipt of loan for companies accounted for at equity and |
|||
| others | 1,018 | 277 | 1,500 |
| Net cash used in investing activities | (182,389) | )64,097( | )385,055( |
| Cash flows from financing activities: | |||
| Dividend paid to equity holders of the Company | (68,796) | )57,330( | )22,912( |
| Dividend paid to non-controlling interests | (303) | - | - |
| Exercise of restricted shares |
15 | - | 20 |
| Issue of share capital (net issue expenses) | - | - | 68,482 |
| Receipt of loans from banks | - | - | 100,000 |
| Repayment of short-term credit from banks, net | 2,330 | )18,306( | )1,694( |
| Acquisition of shares from non-controlling interests | (44,378) | - | - |
| Repayment of lease liabilities | (56,459) | )63,864( | )52,151( |
| Repayment of other liabilities | (6,278) | )4,900( | )12,202( |
| Repayment of loans from banks | (24,375) | )33,125( | )57,679( |
| Net cash provided by (used in) financing activities |
(198,244) | )177,525( | 21,864 |
| Exchange rate differences from foreign currency on | |||
| balances of cash and cash equivalents | 139 | )231( | 6,742 |
| Increase (decrease) in cash and cash equivalents | 42,372 | 113,657 | )111,383( |
| Cash and cash equivalents at the beginning of the year | 300,633 | 186,976 | 298,359 |
| Cash and cash equivalents at the end of the year | 343,005 | 300,633 | 186,976 |
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
| Year ended December 31, | ||||
|---|---|---|---|---|
| 2024 | 2023 | 2022 | ||
| NIS in thousands | ||||
| (a) | Acquisition of initially consolidated company: | |||
| Working capital, net | 12,791 | 91 | 2,616 | |
| Property, plant and equipment | (970) | )1( | )9,950( | |
| Right-of-use assets | (966) | - | )22,972( | |
| Intangible assets | (84,478) | )2,810( | )164,263( | |
| Goodwill | (110,753) | )4,748( | )211,941( | |
| Other non-current assets | - | - | )5,829( | |
| Deferred taxes | 5,415 | 647 | 10,514 | |
| Other non-current liabilities | 29,499 | - | 4,541 | |
| Liability for contingent consideration | 11,409 | 4,299 | 2,800 | |
| Lease liabilities | 966 | - | 28,426 | |
| Non-controlling interests | - | 113 | - | |
| Fund sorting of hedging transactions for consideration | ||||
| of the acquisition | - | - | (2,524) | |
| Exchange rate differences due to deferred | ||||
| consideration | - | - | )597( | |
| (137,087) | )2,409( | )369,179( | ||
| (b) | Significant non-cash transactions: | |||
| Purchase of property, plant and equipment and | ||||
| intangible assets on credit | 2,611 | 5,896 | 1,652 | |
| Acquisition of a company and activity against | ||||
| contingent consideration | 11,409 | 4,299 | 2,800 | |
| Right-of-use asset recognized with corresponding | ||||
| lease liability, net | 56,092 | 143,212 | 79,584 | |
| Recognition of lease receivable asset | 23,969 | - | - | |
| Proceeds from sale of financial assets measured at fair |
||||
| value through profit or loss | 1,365 | - | - | |